Table 2.
Characteristics | Luminal | HER2 | Triple neg | p value | |||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
Median age at diagnosis | 73 years (range 65–92) |
73 years (range 65–94) |
72 years (range 65–87) |
0.592 | |||
Age group | |||||||
Young-old | 246 | 62.6 | 72 | 60.5 | 42 | 71.2 | |
Old–old | 129 | 32.8 | 41 | 34.5 | 12 | 20.3 | 0.276 |
Oldest-old | 18 | 4.6 | 6 | 5.0 | 5 | 8.5 | |
p53-positive | 54 | 13.7 | 37 | 31.1 | 33 | 55.9 | <0.001 |
Grade 3 | 69 | 17.6 | 60 | 50.4 | 35 | 59.3 | <0.001 |
Stage IV at first diagnosis | 21 | 5.3 | 18 | 15.1 | 6 | 10.2 | 0.009 |
Metastases | 57 | 14.5 | 43 | 36.1 | 15 | 25.4 | |
Visceral metastases | 33 | 57.9 | 32 | 74.4 | 11 | 73.3 | 0.184 |
Non-visceral | 24 | 42.1 | 11 | 25.6 | 4 | 26.7 | |
BM | 6 | 1.5 | 9 | 7.6 | 2 | 3.4 | 0.003 |
Overall survival from first diagnosis | 95 months (range 92–116) |
88 months (range 75–106) |
204 months (range 94–155) |
0.058 |